Inside Precision Medicine February 20, 2024
Malorye Branca

More than 275 million previously unreported genetic variants have been identified by the National Institutes of Health’s All of Us Research Program, which has enrolled more than 750,000 people since it was launched in 2018. Notably, half of the genomic data in this study are from participants of non-European genetic ancestry and nearly four million of the newly identified variants are in areas that may be tied to disease risk.

The data release includes 245,388 clinical-grade genome sequences. The findings are reported in Nature.

Real applications of this data are already in the works. In a companion study published in Communications Biology, a research team led by Baylor College of Medicine reviewed the frequency of genes and variants...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Survey / Study, Trends
Revolutionizing Primary Care: The Role of Pharmacogenomics and AI in Personalized Medicine
BioAro Announces Real Time DNA Decoding Technology
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future

Share This Article